AAAAAA
Results:
1-15
|
Results: 15
Authors:
Sternberg, CN
Parmar, MKB
Citation: Cn. Sternberg et Mkb. Parmar, Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer, J CL ONCOL, 19(18), 2001, pp. 21S-27S
Authors:
Parmar, MKB
Griffiths, GO
Spiegelhalter, DJ
Souhami, RL
Altman, DG
van der Scheuren, E
Citation: Mkb. Parmar et al., Monitoring of large randomised clinical trials: a new approach with Bayesian methods, LANCET, 358(9279), 2001, pp. 375-381
Authors:
Vergote, I
Rustin, GJS
Eisenhauer, EA
Kristensen, GB
Pujade-Lauraine, E
Parmar, MKB
Friedlander, M
Jakobsen, A
Vermorken, JB
Citation: I. Vergote et al., Re: New guidelines to evaluate the response to treatment in solid tumors [ovarian cancer], J NAT CANC, 92(18), 2000, pp. 1534-1535
Authors:
Mason, MD
Brewster, S
Moffat, LE
Kirkbride, P
Cowan, RA
Malone, P
Sydes, M
Parmar, MKB
Citation: Md. Mason et al., Randomized trials in early prostate cancer. II: Hormone therapy and radiotherapy for locally advanced disease: A question is still unanswered, CL ONCOL-UK, 12(4), 2000, pp. 215-216
Authors:
Torri, V
Harper, PG
Colombo, N
Sandercock, J
Parmar, MKB
Citation: V. Torri et al., Paclitaxel and cisplatin in ovarian cancer, J CL ONCOL, 18(11), 2000, pp. 2349-2349
Authors:
Duchesne, GM
Bolger, JJ
Griffiths, GO
Roberts, JT
Graham, JD
Hoskin, PJ
Fossa, SD
Uscinska, BM
Parmar, MKB
Citation: Gm. Duchesne et al., A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: Results of Medical Research Council Trial BA09, INT J RAD O, 47(2), 2000, pp. 379-388
Authors:
Qian, W
Parmar, MKB
Sambrook, RJ
Fayers, PM
Girling, DJ
Stephens, RJ
Citation: W. Qian et al., Analysis of messy longitudinal data from a randomized clinical trial, STAT MED, 19(19), 2000, pp. 2657-2674
Authors:
Tierney, JF
Stewart, LA
Parmar, MKB
Citation: Jf. Tierney et al., Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix?, EUR J CANC, 35(3), 1999, pp. 406-409
Authors:
Brady, MF
Thigpen, JT
Vermorken, JB
Parmar, MKB
Citation: Mf. Brady et al., Randomised trials in ovarian cancer: trial design considerations, ANN ONCOL, 10, 1999, pp. 75-82
Authors:
Piccart, MJ
Stuart, GCE
Cassidy, J
Bertelsen, K
Parmar, MKB
Eisenhauer, EA
Kaye, SB
Trope, C
Swenerton, K
Harper, P
Vermorken, JB
Citation: Mj. Piccart et al., Intergroup collaboration in ovarian cancer: a giant step forward, ANN ONCOL, 10, 1999, pp. 83-86
Authors:
Berek, JS
Bertelsen, K
du Bois, A
Brady, MF
Carmichael, J
Eisenhauer, EA
Gore, M
Grenman, S
Hamilton, TC
Hansen, SW
Harper, PG
Horvath, G
Kaye, SB
Luck, HJ
Lund, B
McGuire, WP
Neijt, JP
Ozols, RF
Parmar, MKB
Piccart-Gebhart, MJ
van Rijswijk, R
Rosenberg, P
Rustin, GJS
Sessa, C
Thigpen, JT
Trope, C
Tuxen, MK
Vergote, I
Vermorken, JB
Willemse, PHB
Citation: Js. Berek et al., Advanced epithelial ovarian cancer: 1998 consensus statements, ANN ONCOL, 10, 1999, pp. 87-92
Authors:
Grossman, J
Parmar, MKB
Citation: J. Grossman et Mkb. Parmar, Bayesian analysis, J EPIDEM C, 53(10), 1999, pp. 652-653
Authors:
Masters, JRW
Popert, RJM
Thompson, PM
Gibson, D
Coptcoat, MJ
Parmar, MKB
Citation: Jrw. Masters et al., Intravesical chemotherapy with epirubicin: A dose response study, J UROL, 161(5), 1999, pp. 1490-1493
Authors:
Griffiths, GO
Parmar, MKB
Bailey, AJ
Citation: Go. Griffiths et al., Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long term patient reported symptoms, BR J CANC, 81(7), 1999, pp. 1196-1205
Authors:
Parmar, MKB
Torri, V
Stewart, L
Citation: Mkb. Parmar et al., Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints, STAT MED, 17(24), 1998, pp. 2815-2834
Risultati:
1-15
|